How effective is the female Cervical cancer vaccine? What should women pay attention to in preventing cervical cancer

The emergence of Cervical cancer makes many patients suffer especially. This is a serious disease. We should treat it reasonably at ordinary times, especially for its prevention. We should do a good job.

How effective is the Cervical cancer vaccine

Although the vaccine for Cervical cancer is not perfect, there is no doubt about its practical value. It is undeniable that mainland women are keen to vaccinate Cervical cancer vaccine in Hong Kong and Macao. Many studies have shown that the HPV infection rate of uninfected women has significantly decreased after vaccination, and the immune function of HPV infected people against the virus will also be enhanced after vaccination.

The HPV vaccine for preventing cervical cancer has been approved in China. The news sparked heated discussions as many women believed that getting a cervical cancer vaccine was a one-time solution, and having a vaccine in their bodies meant they no longer had to worry about developing cervical cancer. This is not the case. according to

According to experts, Cervical cancer is the only cancer that can be prevented by vaccines. Cervical cancer is the most lethal and easily preventable type of female cancer in the world. The medical community has made it clear that human papillomavirus (HPV) is the main cause of female Cervical cancer, and 99% of Cervical cancer is related to HPV infection. There are currently over 200 known types of HPV, most of which are unrelated to cervical cancer, and there are over a dozen high-risk types associated with cervical cancer. Among them, hpv16 and hpv18 genotypes have the highest risk, which can cause about 70% of Cervical cancer. The currently available HPV vaccines are mainly targeting HPv16 and HPv18.

Experts say that Cervical cancer vaccine cannot prevent 100%, and 70% to 75% of Cervical cancer is infected with hpv16 or hpv18. The vaccines marketed in China can play a very good role in preventing cervical cancer induced by these two Viroid. In addition, the vaccine has a good cross effect, which can prevent 90% to 95% of Genital wart and low-risk virus infection caused by hpv9 and hpv11. However, this does not mean that all cervical cancer viruses can be intercepted by vaccines. 99% of cervical cancer is associated with HPV infection. Currently, more than 200 HPV viruses have been identified, and there are more than 16, 18, and more high-risk types associated with cervical cancer. According to the proportion of cervical cancer infected with high-risk HPV types 16 and 18, at least 25% of cervical cancer cannot be prevented through existing vaccines, which means there is no guarantee that after receiving the vaccine, it will not be infected with cervical cancer induced by other high-risk viruses.